UK diabetes patients being denied vital prescriptions for testing strips

19 November 2014

Patients in Britain with diabetes are missing out on vital prescriptions that let them keep tabs on their condition, despite repeated warnings, says Diabetes UK. Its poll of 1,300 patients found nearly half had had prescriptions for blood-testing strips refused or restricted.

The Department of Health has previously written to general practitioners (GPs) reminding them not to restrict access to this kit other than for clinical reasons. Doctors say there is a balance to be struck with protecting National Health Service (NHS) resources, reported that public broadcaster the BBC.

In the poll by Diabetes UK, 39% of those who had experienced restrictions to blood-testing strips had type 1 diabetes. While the survey may not be representative of all people with the condition, Diabetes UK says it shows that GPs restricting test strips is a significant issue.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical